Home > Healthcare > Medical Devices > Therapeutic Devices > Diabetes Care Devices Market

Diabetes Care Devices Market Share

Report ID: GMI3250
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Diabetes Care Devices Market Share

The market is highly competitive, featuring a blend of leading global manufacturers and smaller to medium-sized enterprises competing for market share. A critical aspect of market strategy involves the continuous introduction of innovative technologies and devices, such as advanced glucose monitoring systems and smart insulin delivery solutions. Prominent industry leaders significantly influence the market, often driving advancements through substantial investments in research and development.

Additionally, mergers, acquisitions, and strategic partnerships are essential for consolidating market positions and expanding global reach in response to evolving healthcare practices and regulatory frameworks. The growing emphasis on personalized diabetes management, improved patient outcomes, and enhanced user experience continues to shape the competitive landscape, influencing product offerings and healthcare providers' trust in diabetes care device.

Diabetes Care Devices Market Companies

Some of the eminent market participants operating in the diabetes care devices industry include:

Abbott Laboratories
ARKRAY
Ascensia Diabetes Care Holding
B. Braun Melsungen
Becton, Dickinson and Company
Bionime Corporation
DarioHealth Corp.
Dexcom
Dr. Reddy’s Laboratories
Eli Lilly and Company
F. Hoffmann-La Roche
Insulet Corporation
Medtronic
Nova Biomedical
Novo Nordisk
Pendiq
Platinum Equity Advisors
Sanofi
Sinocare
Tandem Diabetes Care
Ypsomed Holding

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global diabetes care devices industry was valued at approximately USD 45.1 billion in 2023 and is estimated to grow at an 11.4% CAGR from 2024 to 2032, driven by advancements in diabetes management technologies.

The blood glucose monitoring devices segment dominated the market in 2023, accounting for a 58.4% market share and a CAGR of 11.6%, as they provide critical information for managing diet, exercise, and insulin dosing.

The U.S. market recorded USD 15.4 billion in 2023, driven by high healthcare expenditures and investments in advanced diabetes care technologies.

Key players in the sector include Abbott Laboratories, ARKRAY, Ascensia Diabetes Care Holding, B. Braun Melsungen, Becton, Dickinson and Company, Bionime Corporation, DarioHealth Corp., Dexcom, and Dr. Reddys Laboratories.